Press Release
Category Added in a WPeMatico Campaign
-
Nuvalent Announces Initiation of ALKAZAR Phase 3 Randomized, Controlled Trial Evaluating Neladalkib for Patients with TKI-naïve ALK-positive NSCLC
CAMBRIDGE, Mass., July 21, 2025 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for…
Read More » -
DCA Opens Today to Strengthen Asia’s Data Centre Network
HONG KONG, July 21, 2025 /PRNewswire/ — Data Center Asia (DCA) debuts today at AsiaWorld-Expo, Hong Kong, marking the exciting…
Read More » -
Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1
– Alixorexton Demonstrated Clinically Meaningful and Statistically Significant Improvements in Wakefulness at All Doses Tested Compared to Placebo in Patients With…
Read More » -
ADSQUIRE Becomes the First Legal Marketing Company in Space
PHILADELPHIA, July 21, 2025 /PRNewswire/ — In a groundbreaking leap for both legal marketing and space exploration, ADSQUIRE, the leading innovator…
Read More » -
IDEAYA Biosciences to Participate in Upcoming July 2025 Investor Relations Event
SOUTH SAN FRANCISCO, Calif., July 21, 2025 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed…
Read More »
